Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3699740010 | Ethinylestradiol 30 microgram and levonorgestrel 150 microgram oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
3699741014 | Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
3699742019 | Ethinyl estradiol 30 microgram and levonorgestrel 150 microgram oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
46717001000001117 | Levonorgestrel 150microgram / Ethinylestradiol 30microgram tablets | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
60503701000001112 | Ethinylestradiol 30microgram / Levonorgestrel 150microgram tablets | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Is a | Ethinylestradiol 30mcg+progestogen | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has active ingredient | Hormone | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has active ingredient | Ethinylestradiol | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has active ingredient | Progesterone | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has active ingredient | Estradiol | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Is a | Product containing ethinylestradiol and levonorgestrel | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has active ingredient | Levonorgestrel | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Is a | Product containing estradiol in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has active ingredient | Ethinylestradiol | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has basis of strength substance | Ethinylestradiol | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has presentation strength numerator unit | microgram | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has active ingredient | Levonorgestrel | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has basis of strength substance | Levonorgestrel | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has presentation strength numerator unit | microgram | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has basis of strength substance | Levonorgestrel | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has presentation strength numerator value | 150 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has basis of strength substance | Ethinylestradiol | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has presentation strength numerator value | 30 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has presentation strength numerator value | 0.03 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has presentation strength numerator value | 0.15 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Is a | Product containing ethinylestradiol and levonorgestrel in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has precise active ingredient | Levonorgestrel | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has precise active ingredient | Ethinylestradiol | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Is a | Product containing only ethinylestradiol and levonorgestrel in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Plays role | Contraceptive therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has precise active ingredient | Levonorgestrel | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has precise active ingredient | Ethinylestradiol | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has manufactured dose form | Oral dose form | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Is a | Ethinylestradiol + Levonorgestrel | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has active ingredient | Ethinylestradiol | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has active ingredient | Levonorgestrel | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Discrete dose form indicator | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | tablet.oral ontology form and route | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Oral route | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has specific active ingredient | Levonorgestrel | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has specific active ingredient | Ethinylestradiol | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has dispensed dose form | Tablet | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Is a | Virtual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Ethinylestradiol+levonorgestrel 30micrograms/150micrograms tablet - product | Is a | False | Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Microgynon 30 tablets (Schering Health Care Ltd) | Is a | True | Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Ovranette tablets (Wyeth Laboratories) | Is a | True | Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Levonorgestrel 150microgram / Ethinylestradiol 30microgram tablets 63 tablet | Is pack of | False | Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Levonorgestrel 150microgram / Ethinylestradiol 30microgram tablets 21 tablet | Is pack of | False | Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Ambelina 150microgram/30microgram tablets (Crescent Pharma Ltd) | Is a | True | Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Levonorgestrel 150microgram / Ethinylestradiol 30microgram tablets 21 tablet | Has VMP | True | Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Levonorgestrel 150microgram / Ethinylestradiol 30microgram tablets 63 tablet | Has VMP | True | Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Levest 150/30 tablets (Morningside Healthcare Ltd) | Is a | True | Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Levest 150/30 tablets (Actavis UK Ltd) | Is a | True | Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Rigevidon tablets (Gedeon Richter (UK) Ltd) | Is a | True | Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Microgynon 30 tablets (Mawdsley-Brooks & Company Ltd) | Is a | True | Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Elevin 150microgram/30microgram tablets (MedRx Healthcare LLP) | Is a | True | Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Ethinylestradiol 30microgram / Levonorgestrel 150microgram tablets (A A H Pharmaceuticals Ltd) | Is a | False | Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Ethinylestradiol 30microgram / Levonorgestrel 150microgram tablets (Actavis UK Ltd) | Is a | False | Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Maexeni 150microgram/30microgram tablets (Lupin (Europe) Ltd) | Is a | True | Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Erlibelle 30microgram/150microgram tablets (Actavis UK Ltd) | Is a | True | Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Leandra 30microgram/150microgram tablets (Genesis Pharmaceuticals Ltd) | Is a | True | Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets